NCT01086215

Registry of AngioJet Use in the Peripheral Vascular System

PEARL II: PEripheral Use of AngioJet® Rheolytic Thrombectomy With a Variety of Catheter Lengths

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 500 (actual)
• Sponsor: Boston Scientific Corporation · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

The Registry involves the collection of information for research and educational purposes only on the use of AngioJet in the peripheral vascular system.

Detailed description

The PEARL II Registry is a prospective, multi-center, observational registry including 500 patients who meet eligibility from up to 50 sites worldwide. Patient participation will be 12 months including post procedure follow-up contact at 3, 6 and 12 months. The study duration is estimated at 36 months. A patient's treatment is determined by the treating physician based on the clinical situation and local practices. In contrast to a randomized, controlled trial, there are no pre-defined experimental interventions.

Conditions

• Peripheral Vascular Disease
• Embolism and Thrombosis
• Venous Thrombosis

Timeline

• Start date: 2010-01-01
• Primary completion: 2013-07-01
• Completion: 2013-09-01
• First posted: 2010-03-15
• Last updated: 2014-11-10
• Results posted: 2014-11-03

Locations

36 sites across 5 countries: United States, Canada, Germany, Italy, Slovakia